Accidentally Injected Mounjaro into Muscle — What It Means and What to Do

You've just injected and something felt different, here's the likely picture

Most people who accidentally inject tirzepatide into muscle notice it because the injection felt sharper than usual, or there was more resistance, or perhaps a small bruise appeared quickly. That sensation makes sense: muscle tissue is denser and better vascularised than the subcutaneous fat layer the KwikPen is designed to reach. The medicine still gets into your system. The concern with an intramuscular injection is not that the dose is lost (it isn't) but that the absorption profile changes.

Subcutaneous tissue releases tirzepatide slowly into the bloodstream, which is exactly what the once-weekly schedule relies on. Muscle tissue can absorb substances faster. In practice this means you might notice side effects, particularly nausea or stomach discomfort, arriving sooner or feeling more pronounced than you'd expect. They should still settle in the same general way as they would after any dose. If symptoms feel unusually severe or persistent beyond a couple of days, that's the moment to contact your prescriber or, if you have severe pain, vomiting or signs of an allergic reaction, seek urgent medical help.

One thing worth letting go of: many people assume that injecting into muscle means the whole dose is wasted or that they need to re-inject. You do not. The tirzepatide is still bioavailable; re-injecting would mean taking a double dose, which carries a real risk of intensified side effects. Leave the dose as it is and note what happened for your next conversation with your clinical team. You can read more about what happens when Mounjaro is injected into muscle for a fuller breakdown of the absorption question.

Why the intramuscular risk exists at the recommended injection sites

The three licensed sites for Mounjaro are the abdomen (avoiding a 5cm radius around the navel), the front and outer thigh, and the outer upper arm. All three carry a layer of subcutaneous fat between skin and muscle, but the depth of that layer varies significantly from person to person and site to site. Choosing the right spot each week matters partly for this reason.

The most common technique errors that lead to an intramuscular injection are inserting the pen at too steep an angle, skipping the pinch-up of skin, or choosing a leaner part of the thigh where the fat layer is thinner. The KwikPen is designed with a fixed needle length that suits most adults injecting into a proper pinch of skin at 90 degrees. If you are lean, your prescriber or the Patient Information Leaflet may guide you toward a different site or approach. The NHS tirzepatide medicines page covers the general technique principles clearly and is worth bookmarking alongside your leaflet.

Rotating sites each week also matters beyond the intramuscular question: repeated injections into exactly the same spot can cause localised tissue changes (lipohypertrophy) that affect absorption even when technique is otherwise correct. A simple rotation plan (abdomen one week, thigh the next, upper arm the week after) keeps each site rested. If you want to revisit the full injection process, the Mounjaro injection guide on this site walks through preparation and aftercare step by step.

When to contact a clinician and what to tell them

Most accidental intramuscular injections need no treatment beyond awareness. You should contact your prescriber, pharmacist or GP if nausea or vomiting is severe enough to prevent you keeping fluids down for more than 24 hours (dehydration becomes a risk), if the injection site develops significant swelling, redness or warmth that doesn't settle within a day or two, or if you have any reason to think you may have hit a blood vessel. Information on accidentally injecting into a vein is covered separately, as that scenario has its own considerations, and there is also dedicated guidance on what happens when tirzepatide enters a vein directly for anyone who wants a fuller picture of that specific risk.

When you speak to your prescriber, tell them which site you used, roughly how deep the needle felt, and what symptoms you noticed and when. That's genuinely enough information for them to advise you. At nume, aftercare is available seven days a week, so you can raise technique questions without waiting until a weekday. For broader reassurance about the tirzepatide programme, the Mounjaro overview page covers what the medicine is, how it works, and the clinical framework around it.

If you are still getting comfortable with injections generally, it can help to know that the specific clinical effects of an intramuscular tirzepatide injection are documented and manageable. The NHS also provides guidance on GLP-1 medicine safety via the NHS tirzepatide medicines page, and reporting any unexpected reaction is straightforward through the MHRA Yellow Card scheme. If you are weighing up whether your treatment plan is still right for you after an incident like this, a free consultation with our prescribers is the clearest next step, they can review your technique, your current dose, and anything else on your mind. Speak to our prescribers through the consultation page.